| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f754fd795dc6b56d4d89fd74562d3d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_075820b9ae95c035f493ab09f8fa1a5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99871b05cd568cc5c5ed2cc88c97e9dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cbaa6cfe5675912afe7c81549104380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bb71248545f234c5e4e374256cba6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59b0cd5cdc2656c1db403dd70205ab27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc0acdb1d057e7dac6f1d610c997773b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105398f6328f959246ad5169a42717ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac55ae26b1369509d8a02febf0e7410c |
| publicationDate |
2014-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8722339-B2 |
| titleOfInvention |
Immunoassay methods |
| abstract |
The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013310266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9658231-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014080736-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927223-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9267133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10006023-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11307203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018045735-A1 |
| priorityDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |